Jonathan Kurche, MD
Assistant Professor, Medicine-Pulmonary Sciences & Critical Care

Photo
Download CV
Medical School:
  • MD, University of Colorado Denver School of Medicine (2012)
Graduate School :
  • PhD, University of Colorado Health Sciences Center (2010)
Undergraduate School:
  • BS, Kansas State University (KS) (2002)
Internship:
  • University of Colorado (University Hospital) Program (2013)
Residency:
  • University of Colorado (University Hospital) Program, Internal Medicine (2014)
Fellowships:
  • University of Colorado, Pulmonary Disease and Critical Care Medicine (2018)
Languages: English
Department: Medicine-Pulmonary Sciences & Critical Care

Professional Titles

  • Assistant Professor

Recognition & Awards

  • Fellow, Parker B. Francis Family Foundation (2019)
    "Epithelial biology of the gain-of-function MUC5B promoter risk variant for IPF"

Research Interests

My research interests include understanding the pathobiology and management of acute respiratory failure and idiopathic pulmonary fibrosis.

Publications

  • Dobrinskikh E, Hennessy CE, Kurche JS, Kim E, Estrella AM, Cardwell J, Yang IV, Schwartz DA. Epithelial Endoplasmic Reticulum Stress Enhances the Risk of Muc5b-associated Lung Fibrosis. Am J Respir Cell Mol Biol. 2023 Jan;68(1):62-74. PubMed PMID: 36108173
  • Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?. Transl Res. 2022 Mar;241:13-24. PubMed PMID: 34547499
  • Kurche JS, Stancil IT, Michalski JE, Yang IV, Schwartz DA. Dysregulated Cell-Cell Communication Characterizes Pulmonary Fibrosis. Cells. 2022 Oct 21;11(20). PubMed PMID: 36291184
  • Stancil IT, Michalski JE, Hennessy CE, Hatakka KL, Yang IV, Kurche JS, Rincon M, Schwartz DA. Interleukin-6-dependent epithelial fluidization initiates fibrotic lung remodeling. Sci Transl Med. 2022 Jul 20;14(654):eabo5254. PubMed PMID: 35857823
  • Ma X, Zhu L, Kurche JS, Xiao H, Dai H, Wang C. Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019. Thorax. 2022 Jun;77(6):596-605. PubMed PMID: 34556551
  • Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?. Transl Res. 2022 Mar;241:13-24. PubMed PMID: 34547499
  • Ma X, Zhu L, Kurche JS, Xiao H, Dai H, Wang C. Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019. Thorax. 2021 Sep 23. [Epub ahead of print] PubMed PMID: 34556551
  • Dobrinskikh E, Estrella AM, Hennessy CE, Hara N, Schwarz MI, Kurche JS, Yang IV, Schwartz DA. Genes, other than Muc5b, play a role in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L440-L450. PubMed PMID: 34160296
  • Gally F, Sasse SK, Kurche JS, Gruca MA, Cardwell JH, Okamoto T, Chu HW, Hou X, Poirion OB, Buchanan J, Preissl S, Ren B, Colgan SP, Dowell RD, Yang IV, Schwartz DA, Gerber AN. The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling. JCI Insight. 2021 Jan 25;6(2). PubMed PMID: 33320836
  • Gally F, Sasse SK, Kurche J, Gruca MA, Cardwell JH, Okamoto T, Chu HW, Hou X, Poirion O, Buchanan J, Preissl S, Ren B, Colgan SP, Dowell RD, Yang IV, Schwartz DA, Gerber AN. The MUC5B-associated variant, rs35705950, resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling. JCI Insight. 2020 Dec 15. [Epub ahead of print] PubMed PMID: 33320836
  • Furusawa H, Cardwell JH, Okamoto T, Walts AD, Konigsberg IR, Kurche JS, Bang TJ, Schwarz MI, Brown KK, Kropski JA, Rojas M, Cool CD, Lee JS, Wolters PJ, Yang IV, Schwartz DA. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures. Am J Respir Crit Care Med. 2020 Nov 15;202(10):1430-1444. PubMed PMID: 32602730
  • Kurche JS, Dobrinskikh E, Hennessy CE, Huber J, Estrella A, Hancock LA, Schwarz MI, Okamoto T, Cool CD, Yang IV, Evans CM, Schwartz DA. Muc5b Enhances Murine Honeycomb-like Cyst Formation. Am J Respir Cell Mol Biol. 2019 Oct;61(4):544-546. PubMed PMID: 31573335
  • Kurche JS, Schwartz DA. Deciphering the Genetics of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2019 Jan 1;199(1):4-5. PubMed PMID: 30130126
View All (13 Total) View Less

Professional Memberships

  • American Thoracic Society, Member

Practice Locations

Rocky Mountain Regional Veterans Administration Medical Center
1700 Wheeling St
Aurora, CO 80045
303-399-8020

Hospital Affiliation
  • University of Colorado Hospital
  • Veterans Affairs Medical Center

Specialty Information

Specialties
  • Critical Care Medicine (2018)
  • Pulmonary Disease, Board Certification (2017, 2017)
Conditions & Treatments
  • Lungs and Breathing - Interstitial Lung Disease
  • Lungs and Breathing
  • Lungs and Breathing - Respiratory Disease

General Information

Medical Schools:
  • MD, University of Colorado Denver School of Medicine (2012)
Graduate Schools:
  • PhD, University of Colorado Health Sciences Center (2010)
Undergraduate Schools:
  • BS, Kansas State University (KS) (2002)
Internships:
  • University of Colorado (University Hospital) Program (2013)
Residency Programs:
  • University of Colorado (University Hospital) Program, Internal Medicine (2014)
Fellowships:
  • University of Colorado, Pulmonary Disease and Critical Care Medicine (2018)
Download CV
Languages: English
Department: Medicine-Pulmonary Sciences & Critical Care
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;